54 related articles for article (PubMed ID: 6772975)
1. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
Der-Ghazarian T; Charntikov S; Varela FA; Crawford CA; McDougall SA
J Neural Transm (Vienna); 2010 May; 117(5):573-83. PubMed ID: 20372943
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.
Feenstra MG; Sumners C; Goedemoed JH; de Vries JB; Rollema H; Horn AS
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):108-15. PubMed ID: 6646238
[TBL] [Abstract][Full Text] [Related]
3. The effect of chronic haloperidol treatment on some cardiovascular parameters in cats.
Bentley GA; Copeland IW
Br J Pharmacol; 1985 Nov; 86(3):737-41. PubMed ID: 4063587
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.
Clark D; Hjorth S; Carlsson A
J Neural Transm; 1985; 62(3-4):171-207. PubMed ID: 2863323
[TBL] [Abstract][Full Text] [Related]
5. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
[TBL] [Abstract][Full Text] [Related]
6. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.
Carlsson A; Kehr W; Lindqvist M
J Neural Transm; 1977; 40(2):99-113. PubMed ID: 323424
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic neurons - alteration in the sensitivity of tyrosine hydroxylase to inhibition by endovenous dopamine after cessation of impulse flow.
Walters JR; Roth RH
Biochem Pharmacol; 1976 Mar; 25(6):649-54. PubMed ID: 6034
[No Abstract] [Full Text] [Related]
8. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
Bannon MJ; Bunney EB; Zigun JR; Skirboll LR; Roth RH
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
[TBL] [Abstract][Full Text] [Related]
9. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
Zharkovskiĭ AM; Nurk AM
Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
[TBL] [Abstract][Full Text] [Related]
10. Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment.
Zarkovsky AM; Nurk AM; Rägo LK; Allikmets LH
Neuropharmacology; 1982 Feb; 21(2):155-8. PubMed ID: 7199630
[TBL] [Abstract][Full Text] [Related]
11. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
[TBL] [Abstract][Full Text] [Related]
12. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
[TBL] [Abstract][Full Text] [Related]
13. Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions.
Fujita N; Saito K; Iwatsubo K; Hirata A; Noguchi Y; Yoshida H
Brain Res; 1980 May; 190(2):593-6. PubMed ID: 7370810
[No Abstract] [Full Text] [Related]
14. Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
Wheeler SC; Roth RH
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):151-9. PubMed ID: 7190650
[TBL] [Abstract][Full Text] [Related]
15. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G
Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
